Medical and Behavioral Correlates of Depression History in Children and Adolescents With Autism Spectrum Disorder

被引:46
|
作者
Greenlee, Jessica L. [1 ]
Mosley, Angela S. [2 ]
Shui, Amy M. [3 ]
Veenstra-VanderWeele, Jeremy [4 ]
Gotham, Katherine O. [2 ]
机构
[1] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA
[2] Vanderbilt Univ, Med Ctr, Dept Psychiat, Nashville, TN USA
[3] Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA
[4] Columbia Univ, Dept Psychiat, Med Ctr, New York, NY USA
关键词
PERVASIVE DEVELOPMENTAL DISORDERS; PSYCHIATRIC-DISORDERS; ASPERGER-SYNDROME; GASTROINTESTINAL DISORDERS; INTERNALIZING SYMPTOMS; MAJOR DEPRESSION; SOMATIC SYMPTOMS; ANXIETY; COMORBIDITY; PREVALENCE;
D O I
10.1542/peds.2015-2851I
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
BACKGROUND AND OBJECTIVES: Depression is commonly associated with autism spectrum disorder (ASD) across the life span. We sought to identify medical and behavioral problems associated with a history of a parent-reported diagnosis of depression in a large sample of school-aged children and adolescents with ASD. METHODS: A sample of 1272 participants (aged 6-17 years; mean [SD]: 9.56 [2.79] years) from the Autism Speaks Autism Treatment Network consortium were divided into "ever-depressed" (n = 89) and "nondepressed" (n = 1183) groups on the basis of caregiver endorsement of children's current or previous diagnoses of depression. RESULTS: In total, 7.0% of children with ASD (4.8% of those aged 6-12 years and 20.2% of those aged 13-17 years) were reported to have a history of a depression diagnosis. Positive depression history was associated with greater chronological age, higher IQ, and Asperger disorder diagnosis. After controlling for age, IQ, and within-spectrum categorical diagnosis, the ever-depressed group exhibited significantly greater rates of seizure disorders (odds ratio = 2.64) and gastrointestinal problems (odds ratio = 2.59) and trend-level differences in aggression, somatic complaints, and social impairments. The groups did not differ in autism severity, repetitive behaviors, sleep problems, eating problems, self-injurious behavior, or current intervention use. CONCLOSIONS: Co-occurring depression is a particularly common problem in higher-functioning older children within the Autism Treatment Network. Our findings indicate that children with ASD and a history of a depression diagnosis are more likely to also have co-occurring medical problems, although the presence and direction of causality is unclear.
引用
下载
收藏
页码:S105 / S114
页数:10
相关论文
共 50 条
  • [31] An update on pharmacotherapy for autism spectrum disorder in children and adolescents
    Ji, Na Young
    Findling, Robert L.
    CURRENT OPINION IN PSYCHIATRY, 2015, 28 (02) : 91 - 101
  • [32] Gait Patterns Of Children And Adolescents With Autism Spectrum Disorder
    Wang, Henry
    Wu, Xinye
    Dickin, D. Clark
    Bassette, Laura
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2021, 53 (08): : 133 - 133
  • [33] Emotion Regulation in Children and Adolescents With Autism Spectrum Disorder
    Samson, Andrea C.
    Hardan, Antonio Y.
    Podell, Rebecca W.
    Phillips, Jennifer M.
    Gross, James J.
    AUTISM RESEARCH, 2015, 8 (01) : 9 - 18
  • [34] An update on pharmacotherapy of autism spectrum disorder in children and adolescents
    Goel, Ritu
    Hong, Ji Su
    Findling, Robert L.
    Ji, Na Young
    INTERNATIONAL REVIEW OF PSYCHIATRY, 2018, 30 (01) : 78 - 95
  • [35] Parental aspirations of children and adolescents with autism spectrum disorder
    Tan, K.
    Poon, K.
    JOURNAL OF APPLIED RESEARCH IN INTELLECTUAL DISABILITIES, 2010, 23 (05) : 465 - 465
  • [36] Oxidative Imbalance in Children and Adolescents with Autism Spectrum Disorder
    Ozturk, Onder
    Basay, Omer
    Basay, Burge Kabukcu
    Alacam, Huseyin
    Buber, Ahmet
    Kaptanoglu, Bunyamin
    Enli, Yasar
    Dogan, Mustafa
    Tuncer, Omer Faruk
    Kardesler, Aysen Cetin
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2016, 26 (03): : 257 - 264
  • [37] Food education for children or adolescents with an autism spectrum disorder
    Luisier, Anne-Claude
    Berod, Annick Clerc
    Bensafi, Moustafa
    Petitpierre, Genevieve
    ENFANCE, 2019, (02) : 201 - 222
  • [38] Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder
    Sikich, L.
    Kolevzon, A.
    King, B. H.
    McDougle, C. J.
    Sanders, K. B.
    Kim, S-J
    Spanos, M.
    Chandrasekhar, T.
    Trelles, M. D. P.
    Rockhill, C. M.
    Palumbo, M. L.
    Cundiff, A. Witters
    Montgomery, A.
    Siper, P.
    Minjarez, M.
    Nowinski, L. A.
    Marler, S.
    Shuffrey, L. C.
    Alderman, C.
    Weissman, J.
    Zappone, B.
    Mullett, J. E.
    Crosson, H.
    Hong, N.
    Siecinski, S. K.
    Giamberardino, S. N.
    Luo, S.
    She, L.
    Bhapkar, M.
    Dean, R.
    Scheer, A.
    Johnson, J. L.
    Gregory, S. G.
    Veenstra-VanderWeele, J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (16): : 1462 - 1473
  • [39] Treatment of insomnia in children and adolescents with autism spectrum disorder
    Shelton, Althea Robinson
    Malow, Beth
    LANCET CHILD & ADOLESCENT HEALTH, 2020, 4 (10): : 716 - 717
  • [40] Recent Advances in the Pharmacological Management of Behavioral Disturbances Associated with Autism Spectrum Disorder in Children and Adolescents
    Lamy, Martine
    Pedapati, Ernest V.
    Dominick, Kelli L.
    Wink, Logan K.
    Erickson, Craig A.
    PEDIATRIC DRUGS, 2020, 22 (05) : 473 - 483